Intention-to-treat outcomes of patients with hepatocellular carcinoma receiving immunotherapy before liver transplant: the multicenter VITALITY study

已完结 10 由绝绝子发布于 2024/10/11 19:44:55

DOI:10.1016/j.jhep.2024.09.003
作者：Parissa Tabrizian M.D. MSc FACS, Matthew L. Holzner M.D., Veeral Ajmera M.D., Amy K. Kim M.D., Kali Zhou M.D., Gabriel T. Schnickel M.D., Kelly Torosian M.D., Maarouf Hoteit M.D., Rebecca Marino M.D.,
文献类型：期刊论文
补充材料：只需要正文

Elsevier

Abstract：Background AimsThe use of immune checkpoint inhibitors (ICIs) in patients with advanced hepatocellular carcinoma (HCC) has become widespread with encouraging outcomes in the neoadjuvant set

应助信息

求助已完结，文件已删除 如有需求请重新发布求助一键发布

感谢使用Book学术
本站所有文献仅供个人学习和参考，请勿将文件进行传播。共同遵守网站规定和相关知识产权规定。

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:JAMAMethods and Statistical Analysis in a Study of Liver Resection vs Nonsurgical Treatments for Hepatocellular Carcinoma.